Investing Profile
Jill carroll
Your Intro Paths to Jill carroll
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Jill is a member of
Duke University Network
126 CONNECTIONS
Find Jill carroll on
cbCurrent Investing Position
SR One Principal
Investments On Record
11
Jill carroll's Investments On Record (8)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
AirNexis Therapeutics | Series AJan 2026$200M | $200M |
Poplar Therapeutics | Series AJan 2026$50M | $50M |
Avalyn Pharma | Series DJul 2025$100M Series CSep 2023$180M | $310M |
Odyssey Therapeutics | Series BOct 2022$170M Series ADec 2021$220M | $700M |
HotSpot Therapeutics | Series CNov 2021$100M Series BMay 2020$65M | $210M |
Arch Oncology | Series AAug 2016$86M | $86M |
Second Genome | Series BApr 2016$51M | $58M |
AGTC | Series BNov 2012$38M | $38M |
Jill carroll's Experience
Principal S.R. One Ltd2011 - Present
VP, Corporate Development Limerick Biopharma2010 - 2011
Sr Director, Strategic Planning & Corporate Development Dynavax Technologies2004 - 2010
Director, Market Analysis Clearview Projects2001 - 2004
Consultant Mercer Management Consulting1999 - 2001
Jill carroll's Education
Johns Hopkins University MS Biochemistry
Duke University BS Chemistry
Investors who invest with Jill carroll
Founders who looked at Jill carroll's profile also looked at these Scouts & Angels